RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo …
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo … TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced a manufacturing agreement with Cosmo Pharmaceuticals NV (SIX: COPN) (“Cosmo”) to further expand manufacturing capacity for opaganib (Yeliva®, […]
Read More